Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 131.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 134.00
  • 52 Week Low: 83.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 89,328
  • Market Cap: £110.93m
  • RiskGrade: 196

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
49.88% above the market average49.88% above the market average49.88% above the market average49.88% above the market average49.88% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
19.50% above the market average19.50% above the market average19.50% above the market average19.50% above the market average19.50% above the market average
40.74% above the sector average40.74% above the sector average40.74% above the sector average40.74% above the sector average40.74% above the sector average
Price Book Ratio
56.22% below the market average56.22% below the market average56.22% below the market average56.22% below the market average56.22% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
73.15% above the market average73.15% above the market average73.15% above the market average73.15% above the market average73.15% above the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average
Price Chg 3m
81.90% above the market average81.90% above the market average81.90% above the market average81.90% above the market average81.90% above the market average
78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
50.23% below the market average50.23% below the market average50.23% below the market average50.23% below the market average50.23% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
61.76% below the market average61.76% below the market average61.76% below the market average61.76% below the market average61.76% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
18.2% below the market average18.2% below the market average18.2% below the market average18.2% below the market average18.2% below the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average
Operating Profit Loss
60.79% below the market average60.79% below the market average60.79% below the market average60.79% below the market average60.79% below the market average
8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
0.22% above the market average0.22% above the market average0.22% above the market average0.22% above the market average0.22% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average
Cash
22.62% above the market average22.62% above the market average22.62% above the market average22.62% above the market average22.62% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
62.98% above the market average62.98% above the market average62.98% above the market average62.98% above the market average62.98% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Buys 1y
3.56% above the market average3.56% above the market average3.56% above the market average3.56% above the market average3.56% above the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 131.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 134.00
52 Week Low 83.50
Volume 89,328
Shares Issued 84.68m
Market Cap £110.93m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.7% below the market average34.7% below the market average34.7% below the market average34.7% below the market average34.7% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average
Price Trend
90.36% above the market average90.36% above the market average90.36% above the market average90.36% above the market average90.36% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
14.33% above the market average14.33% above the market average14.33% above the market average14.33% above the market average14.33% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

Diaceutics Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
08:33 35,570 @ 131.00p
14:34 5,000 @ 131.00p
14:00 10,000 @ 131.00p
14:00 10,000 @ 131.00p
13:17 150 @ 131.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page